
Outcomes Items:
Our Outcomes
“Since installing ePRISM® we have lowered our bleeding rate to 1.2%, 50 percent of the national average.” Dave Strelow, Director, CV Lab Services, Mid America Heart Institute


Click the title to read full article.
American Heart Association Late-Breaking Clinical Trial Report New Predictive Modeling Tool Helps Identify High-Risk PCI Patients at Point of Care New Product Announcement ePRISM® and Saint Luke’s Hospital, Kansas City nominated as finalist for ClearMark Award HOS and ACC form Strategic Partnership HOS Announces New President & Chief Sales & Marketing Officer HOS Announces New CEO PRESS - A New Consent Form PRESS - Heart Stents PRESS - Risks More Clear Through New Consent Form PRESS - Calculating risks of cardiac treatments PRESS - Amerinet Puts HOS on Contracted Supplier List